Generali Investments Management Co LLC Sells 4,351 Shares of Lam Research Corporation $LRCX

Key Points

• Generali Investments Management cut its Lam Research position by 43.2% in the second quarter, selling 4,351 shares and retaining 5,731 shares valued at $2.48 million. Institutional investors collectively own 84.61% of the company.
• Lam Research beat quarterly expectations with earnings of $1.82 per share versus the $1.69 consensus, while revenue rose 30% year over year to $6.72 billion. The company issued fiscal Q1 2027 EPS guidance of $2.00–$2.30.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $358.47, despite recent insider selling and a share price of $306.40 at the time of the report.

Generali Investments Management Co LLC lowered its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 43.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,731 shares of the semiconductor company's stock after selling 4,351 shares during the quarter. Generali Investments Management Co LLC's holdings in Lam Research were worth $2,483,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. E. Ohman J or Asset Management AB increased its holdings in Lam Research by 2.6% during the 2nd quarter. E. Ohman J or Asset Management AB now owns 57,351 shares of the semiconductor company's stock worth $24,852,000 after purchasing an additional 1,430 shares during the period. BFI Infinity Ltd. purchased a new stake in shares of Lam Research in the 2nd quarter worth $234,000. Redhawk Wealth Advisors Inc. grew its position in shares of Lam Research by 808.2% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 8,555 shares of the semiconductor company's stock worth $3,707,000 after buying an additional 7,613 shares in the last quarter. LVM Capital Management Ltd. MI bought a new position in shares of Lam Research during the 2nd quarter worth $217,000. Finally, Fulton Bank N.A. increased its stake in shares of Lam Research by 14.3% during the second quarter. Fulton Bank N.A. now owns 20,019 shares of the semiconductor company's stock valued at $8,675,000 after buying an additional 2,500 shares during the period. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $306.40 on Tuesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The company has a market cap of $383.17 billion, a PE ratio of 53.19, a P/E/G ratio of 1.25 and a beta of 1.84. The business has a 50-day simple moving average of $339.68 and a two-hundred day simple moving average of $280.63. Lam Research Corporation has a fifty-two week low of $94.11 and a fifty-two week high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same quarter in the previous year, the firm earned $1.33 earnings per share. The company's revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities analysts expect that Lam Research Corporation will post 9.24 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th were given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Wednesday, June 17th. Lam Research's payout ratio is currently 18.06%.

Analyst Ratings Changes

Several research firms recently weighed in on LRCX. The Goldman Sachs Group restated a "buy" rating and issued a $290.00 price objective on shares of Lam Research in a report on Thursday, April 23rd. UBS Group restated a "buy" rating and set a $375.00 target price (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. BNP Paribas Exane increased their target price on Lam Research from $250.00 to $260.00 and gave the company a "neutral" rating in a research report on Thursday, April 23rd. Barclays reiterated an "overweight" rating and issued a $335.00 price target (up from $275.00) on shares of Lam Research in a report on Thursday, June 11th. Finally, Weiss Ratings lowered Lam Research from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Lam Research has an average rating of "Moderate Buy" and an average target price of $358.47.

Insider Buying and Selling at Lam Research

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the company's stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director owned 87,142 shares in the company, valued at approximately $29,192,570. This represents a 17.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the firm's stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares of the company's stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is owned by corporate insiders.

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source